Ethyl 4-hydroxy-2-(trifluoromethyl)pyrimidine-5-carboxylate, 95.0%, 1g

OROXYLIN A, 98%, 250mg

3,5-Dichloro-N-methylbenzylamine hydrochloride, 97%, 1g

Fmoc-Cys(Acm)-OH, 97%, 5g

Biocular iScope IS.1152-EPLi con objetivos E-plan IOS y mesa cruzada sin bastidor (infinito)

5-Iodo-2'-deoxyuridine, 95.0%, 1g

1-Benzyl-3,5-dibromo-1H-1,2,4-triazole, 97.0%, 5g

thieno[2,3-d]isothiazol-3(2H)-one 1,1-dioxide, 95.0%, 1g

4-Chloro-2-hydroxy-3-iodobenzaldehyde, 95%, 100mg

5-[(3,6-Dihydro-4-phenyl-1(2H)-pyridinyl)methyl]-2-methyl-4-pyrimidinaminedihydrochloride, 98%, 5mg

4-Bromo-3-chlorobenzaldehyde, 97.0%, 25g

2,4,6-Trimethoxybenzenethiol, 97%, 100mg

2-Ethoxy-4-nitrobenzoic acid, 99.0%, 250mg